2005
DOI: 10.1182/blood-2004-06-2483
|View full text |Cite
|
Sign up to set email alerts
|

Ex vivo culture of Fancc-/- stem/progenitor cells predisposes cells to undergo apoptosis, and surviving stem/progenitor cells display cytogenetic abnormalities and an increased risk of malignancy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
86
0

Year Published

2005
2005
2018
2018

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 62 publications
(87 citation statements)
references
References 51 publications
1
86
0
Order By: Relevance
“…Those abnormalities appeared to arise specifically from cells that had undergone prolonged transduction culture, but remained untransduced, and, consequently, genetically uncorrected. 21 Finally, this protocol represents an ideal platform for subsequent in vivo selection to achieve complete phenotype correction and high-level therapeutic chimerism required for some applications. Clearly, studies in large animal models and targeting human CD34-enriched progenitor cell populations are needed to confirm the feasibility of our strategy.…”
mentioning
confidence: 99%
“…Those abnormalities appeared to arise specifically from cells that had undergone prolonged transduction culture, but remained untransduced, and, consequently, genetically uncorrected. 21 Finally, this protocol represents an ideal platform for subsequent in vivo selection to achieve complete phenotype correction and high-level therapeutic chimerism required for some applications. Clearly, studies in large animal models and targeting human CD34-enriched progenitor cell populations are needed to confirm the feasibility of our strategy.…”
mentioning
confidence: 99%
“…FA-D1, FA-D2, FA-M), AML is not spontaneously generated in the FA mouse models generated so far. Studies conducted in Fancc -/-mice have shown, however, that the ex vivo culture and/or incubation of Fancc -/-BM cells with TNF-α, whose expression is significantly increased in FA patients, induces leukemic clonal evolution after transplantation [109,110], suggesting that leukemia development in FA patients could be at least partially related to the deregulated expression of this cytokine. Fanca -/-as well as Fancc -/-mice, and also mice with a hypomorphic mutation in Brca2/Fancd1 (FA-D1 mice) constitute the FA mouse models more frequently used both to understand the role of FA genes in HSCs functionality, and also to evaluate the preclinical efficacy of new therapies in FA.…”
Section: Lessons From Fanconi Anemia Mouse Modelsmentioning
confidence: 99%
“…Competitive repopulation experiments were conducted as previously described in primary and secondary recipients [36,38]. Briefly, LDMC from 1 ml (cohort 1) or 2 ml (cohort 2) of the PB of donor WT, Fanca −/− or Fancc −/− mice treated with G-CSF, AMD3100 or both were transplanted along with 7.5 × 10 5 BoyJ competitor BM LDMC into WT (8-12 week old) lethally irradiated recipients (1100 rads).…”
Section: Competitive Repopulation Assaysmentioning
confidence: 99%
“…The identification of these genes raises the potential of using gene transfer technology to express the functional cDNA in autologous stem cells. The BM hypoplasia commonly observed in FA patients [1] and the reduced repopulating ability of stem cells in mice containing a disruption of the murine homologue of an FA gene [29,30] led to the hypothesis that autologous, geneticallycorrected stem cells would have an engraftment and proliferation advantage.…”
Section: Introductionmentioning
confidence: 99%